Jasper Therapeutics (JSPR) Amortizatization of Intangibles (2021 - 2023)
Jasper Therapeutics (JSPR) posted Amortizatization of Intangibles of $102000.0 for Q2 2023, up 3.03% on a QoQ basis from $99000.0 in Q1 2023, and up 7.37% year-over-year from $95000.0 in Q2 2022.
Analysis
Jasper Therapeutics (JSPR) Amortizatization of Intangibles (2021 - 2023) Analysis & Trends
Jasper Therapeutics has reported Amortizatization of Intangibles for 3 years, with the latest figure at $102000.0 in Q2 2023.
- On a quarterly basis, Amortizatization of Intangibles rose 7.37% year-over-year to $102000.0 in Q2 2023; TTM through Jun 2023 was $385000.0, a 146.79% increase from a year earlier, with the FY2022 full-year figure at $335000.0, up 77.25% from the prior year.
- Amortizatization of Intangibles was $102000.0 for Q2 2023 at Jasper Therapeutics, up from $99000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $102000.0 in Q2 2023, with the low at -$31000.0 in Q3 2021.
- Average Amortizatization of Intangibles over 3 years is $72500.0, with a median of $92000.0 recorded in 2022.
- The largest YoY upside for Amortizatization of Intangibles was 390.32% in 2022 against a maximum downside of 41.67% in 2022.
- Over 3 years, Amortizatization of Intangibles stood at $36000.0 in 2021, then surged by 161.11% to $94000.0 in 2022, then rose by 8.51% to $102000.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at $102000.0 (Q2 2023), $99000.0 (Q1 2023), and $94000.0 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.39 Mn |
| 10 | Jasper Therapeutics | 20.11 Mn | 20.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 102,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 94,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Jun 30, 2022 | 95,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | -31,000.00 |
| Jun 30, 2021 | 88,000.00 |
| Mar 31, 2021 | 96,000.00 |